SECFilingvia Quantisnow
Exicure Inc. logo

XCUR: SEC Form PRE 14A filed by Exicure Inc.

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight
Quantisnow AI summary

Exicure proposes raising authorized common stock from 200M to 400M shares and seeks approval to issue over 20% in future private…

What this filing says

Exicure has filed a preliminary proxy statement for its 2026 Annual and Special Meeting of Stockholders, to be held online on December 2, 2026. Stockholders will vote on electing two Class III directors, ratifying CBIZ CPAs P.C. as auditor, approving a private financing above 20% of common stock under Nasdaq Rule 5635(d), adopting a 2026 omnibus equity incentive plan, and increasing authorized common stock from 200,000,000 to 400,000,000 shares. For shareholders, the authorized share increase and the financing approval could both dilute existing holdings if used.

Key figures

Meeting date
December 2, 2026
Current authorized common stock
200,000,000 shares
Proposed authorized common stock
400,000,000 shares
Private financing threshold
more than 20%
Class III director nominees
two
Maximum aggregate gross proceeds (equity plan)
up to $10,000,000

Positive for shareholders

  • The authorized share increase would give the company room for future financing and equity grants.

Negative for shareholders

  • Approving issuance above 20% of outstanding common stock could dilute existing shareholders.
  • Doubling authorized common stock would allow substantially more shares to be issued without a further vote.
  • The equity incentive plan would add new awards that could dilute existing holders.

Written by Quantisnow AI from this filing. Not financial advice.

Key terms

Preliminary proxy statement:
A draft version of the document a company sends to shareholders before a meeting, filed with the SEC for review before final distribution.
Nasdaq Listing Rule 5635(d):
A Nasdaq rule requiring shareholder approval before a company issues shares equal to 20% or more of its outstanding common stock in certain private deals.
Dividend equivalent rights:
Awards that credit the holder with the value of cash dividends that would have been paid on the underlying shares.
Omnibus equity incentive plan:
A single plan that lets a company grant several kinds of equity awards, such as stock options and restricted stock units, to employees and directors.

FAQ

When and how will Exicure hold its 2026 annual and special meeting?

The meeting will be held virtually and exclusively online via a live audio-only webcast on December 2, 2026, at 5:00 p.m. Central Time.

What is Exicure asking shareholders to approve on authorized shares?

Exicure proposes increasing its authorized common stock from 200,000,000 shares to 400,000,000 shares, with a corresponding change to total authorized capital stock.

What is the maximum size of the equity plan's proceeds?

The filing states maximum aggregate gross proceeds of up to $10,000,000 under the plan as excerpted in the document.

Historical context for XCUR

Across the 11 sessions after earlier XCUR headlines, the stock closed higher 6 times and lower 4 times, with a median move of 2.3% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.

Keep researching XCUR

Quantisnow market dataNASDAQ
Exicure Inc. logo
XCUR
Exicure Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Get push alerts for XCUR

Follow XCUR and get a push notification the moment its next story breaks.

Full XCUR profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track XCUR (Exicure Inc.) and more on Quantisnow.